样式: 排序: IF: - GO 导出 标记为已读
-
OPtimal TIming of antenatal COrticosteroid administration in pregnancies complicated by early-onset fetal growth REstriction: results of a large, multicenter cohort study (the OPTICORE study). Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-16 Mette VAN DE Meent,Wessel Ganzevoort,Sanne J Gordijn,Elisabeth M W Kooi,Wes Onland,Johannes J Duvekot,Eline VAN DER Wilk,René F Kornelisse,Salwan Al-Nasiry,Reint Jellema,H Marieke Knol,Gwendolyn T R Manten,Susanne M Mulder-DE Tollenaer,Jan B Derks,Floris Groenendaal,Mireille N Bekker,Ewoud Schuit,A Titia Lely,Judith Kooiman
BACKGROUND Early-onset fetal growth restriction as consequence of placental insufficiency frequently requires iatrogenic, preterm birth. Administration of antenatal corticosteroids reduces risks of neonatal morbidity and mortality following preterm birth and is most beneficial if the neonate is delivered within two weeks following treatment. International guidelines on fetal growth restriction pregnancies
-
Assessment of the vaginal microbiota before and after use of hyperosmolal lubricant during transvaginal ultrasound. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-16 Sarah E Brown,Xin He,Laurence Magder,Christina A Stennett,Sarah J Robbins,Elizabeth D Johnston,Daniel Morgan,Khalil Ghanem,Jacques Ravel,Katrina Mark,Rebecca M Brotman
BACKGROUND Vaginal lubricants are commonly used during sexual activity and clinical procedures such as transvaginal ultrasound (TVUS). Epidemiologic and laboratory studies indicate hyperosmolal water-based lubricants may disrupt the vaginal microbiota, particularly the beneficial Lactobacillus spp. These bacteria play a critical role in protecting against sexually transmitted infection acquisition
-
FIRST-TRIMESTER NUCLEAR MAGNETIC RESONANCE-BASED METABOLOMIC PROFILING INCREASES THE PREDICTION OF GESTATIONAL DIABETES MELLITUS. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-16 Luiza Borges Manna,Argyro Syngelaki,Peter Würtz,Aki Koivu,Mikko Sairanen,Tuukka Pölönen,Kypros H Nicolaides
OBJECTIVE To investigate whether nuclear magnetic resonance (NMR)-based metabolomic profiling of maternal blood can be used for first-trimester prediction of gestational diabetes mellitus (GDM). STUDY DESIGN This was a prospective study of 20,000 women attending for routine pregnancy care at 11-13 weeks' gestation. Metabolic profiles were assessed using a high-throughput NMR metabolomics platform.
-
Bladder instillations versus onabotulinumtoxinA for interstitial cystitis/bladder pain syndrome - A response. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-15 Eva K Welch,Katherine L Dengler,Christine M Vaccaro
-
Z-score-based post-test risk as an alternative risk metric to positive predictive value following positive noninvasive prenatal screening. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-15 Emily Gaudet,Fredrik Persson,Matthew Saidel
Noninvasive prenatal screening (NIPS) is a long-established and widely used methodology to screen pregnancies for the most common prenatal chromosomal aneuploidies. Since 2017, positive result reports have typically included a positive predictive value (PPV) to assist informed clinical decision making. PPV is calculated based on an assay's sensitivity and specificity for a particular condition, and
-
Relationship between pre-pregnancy body-mass-index and gestational age-specific risk of stillbirth and perinatal death in women with chronic hypertension. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-12 Jeffrey N Bone,J O S E P H Ks,M A G E E Laura A,M A Y E R Chantal,L I S O N K O V A Sarka
BACKGROUND Obesity is a risk factor for stillbirth and perinatal death and is often accompanied by chronic hypertension; however, there are few studies on the relationship between pre-pregnancy BMI and gestational age (GA)-specific rates of stillbirth and perinatal death in women with chronic hypertension. OBJECTIVE The objective of this study was to examine the relationship between pre-pregnancy BMI
-
Bladder instillations versus onabotulinumtoxinA for interstitial cystitis/bladder pain syndrome. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-12 Murat Can Karaburun,Omer Gulpinar
-
First-trimester fetal fraction measurement in non-invasive prenatal testing: a response. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-12 Ellis C Becking,Peter G Scheffer,Mireille N Bekker
-
A randomised crossover design study comparing the pharmacokinetics and pharmacodynamics of two single doses of oral Aspirin (75 mg v 150mg) in pregnant women at risk of pre-eclampsia (DORA): A Response. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-12 Raya Vinogradov,Oisín N Kavanagh,Farhad Kamali,Stephen Robson
-
Cost-effectiveness of BRCA1 with prenatal carrier screening. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-11 Shayan M Dioun,Jason D Wright,Melissa K Frey
-
Possible misunderstanding about use of a high-dimensional propensity score algorithm to augment clinical knowledge of potential confounding in urogynecology research. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-11 Erin A Brennand,Natalie V Scime,Beili Huang
-
Incorporation of BRCA1 testing into prenatal carrier screening for hereditary breast and ovarian cancer prevention should take carrier rates into account. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-11 Pengfei Wu,Junyi Zhou,Yangyang Zhang
-
Mitigating Feature Importance Bias in Regression Models for Clinical Decision-Making. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-11 Yoshiyasu Takefuji
-
Collaborative Approaches to Enhance Pregnancy Outcomes through Fetal cfDNA Insights. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-11 Xinyue Yang,Zhiqiang Zhang
-
Enhancing preeclampsia prevention: insights from aspirin dosage studies. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-11 Jiayang Dong,Zhiqiang Zhang,Xinyue Yang
-
GENITAL HERPES ZOSTER - AN UNUSUAL BUT IMPORTANT CAUSE OF ACUTE NONTRAUMATIC VULVAR ULCERS. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-10 Joana Galvão,Marta Xavier,Joana Ventura Lourenço,Inês Gouveia,Mónica Melo,Ana Nogueira,Inês Nunes
-
More than the passage of time: neonatal health and active labor duration, the mediating role of chorioamnionitis. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-09 Ellen L Tilden,Katherine Kissler,Leslie Myatt,Louise Lundborg,Michelle Turney,Marit L Bovbjerg,Elise N Erickson
BACKGROUND Labor intervention is intended to prevent perinatal morbidity and mortality. Labor durations traditionally defined as 'dystocia' drive primary cesarean birth rates, yet there is mixed evidence about the association between labor duration and poor neonatal outcomes. Using latent class analysis to study unknown patterns of neonatal health can refine understanding of these relationships and
-
Pregnancy Outcomes in Type 2 Diabetes: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-09 Naomi S Clement,Ahmad Abul,Rachel Farrelly,Helen R Murphy,Karen Forbes,Nigel A B Simpson,Eleanor M Scott
OBJECTIVE Type 2 diabetes (T2D) now accounts for the majority of pre-existing diabetes affecting pregnancy in the UK. Our aim was to determine its impact on pregnancy outcomes compared to type 1 diabetes (T1D), gestational diabetes (GDM) and non-diabetes pregnancies. DATA SOURCES PubMed was searched 1 January 2009-2024. STUDY ELIGIBILITY CRITERIA Cohort observational studies reporting original data
-
Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-06 Marian Jarlenski,Wei-Hsuan LoCiganic,Qingwen Chen,Sabnum Pudasainy,Julie M Donohue,Evan S Cole,Elizabeth E Krans
OBJECTIVES To determine the associations between trajectories of buprenorphine utilization and dose during pregnancy on maternal and neonatal health outcomes. STUDY DESIGN Retrospective cohort study among 2,925 pregnant persons with opioid use disorder, followed from the estimated start date of pregnancy through 90 days after delivery. We used administrative healthcare data from Medicaid-enrolled individuals
-
Associations of Obesity with Post-Treatment Risks of Cervical Precancer and Cancer. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-06 Megan A Clarke,Brian Befano,Nicolas Wentzensen,Li C Cheung,Didem Egemen,Philip E Castle,Mark Schiffman,Patricia E Goldhoff,Tracy S Seo,Elizabeth J Suh-Burgmann,Nancy Poitras,Laurie A Fuller,Soora Wi,Thomas Lorey,Nina R Shah
BACKGROUND Individuals with obesity have an increased risk of cervical cancer, in part related to challenges associated with cervical sampling and visualization that result in missed detection of cervical precancers. The influence of obesity on the effectiveness of excisional treatment of detected cervical precancers and post-treatment disease risk is unknown. OBJECTIVES The aim of this study was to
-
Mapping genetic susceptibility to spontaneous preterm birth: Analysis of Utah pedigrees to find inherited genetic factors. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-06 Tsegaselassie Workalemahu,Erin A S Clark,Michael J Madsen,Zhe Yu,Susan E Dalton,M Sean Esplin,Tracy Manuck,Deborah Neklason,Chen-Han Wilfred Wu,Lynn B Jorde,Nicola J Camp,Robert M Silver,Michael W Varner
BACKGROUND Spontaneous preterm birth (SPTB) is the leading cause of neonatal morbidity and mortality. It is a final common pathway for multiple etiologies, some of which are well known while others likely remain to be identified. Despite recent advancements in identifying genetic risk factors, the mechanisms of many SPTBs remain poorly understood due to the phenotypic heterogeneity and complexity.
-
Characteristics, intrapartum cardiotocography patterns, and postnatal brain imaging findings for cerebral palsy subtypes. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-04 Shoichi Magawa,Masahiro Nakao,Yukiko Nanba,Hideaki Suzuki,Mitsutoshi Iwashita,Akira Oka,Tomoaki Ikeda
-
Human-written vs ChatGPT-generated abstract: some concerns. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-12-01 Shigeki Matsubara
-
Double-blinded randomized controlled trial of Erbium-YAG Laser to treat Female Stress Urinary Incontinence. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-25 Patricia Lee,Darian Perruzza,Humara Edell,Stephanie Jarvi,Katherine Kim,Razia Sultana,Nasrin Alavi,Alex Kiss,Xingshan Cao,Louise-Helene Gagnon,Janet Bodley,Lesley Carr,Sender Herschorn,Rose Kung
BACKGROUND Stress urinary incontinence affects approximately 40% of adult females and is often treated surgically. Minimally invasive laser vaginal therapy to treat stress urinary incontinence has become widely available, but the efficacy of this novel therapy is unclear. OBJECTIVE To determine the efficacy of Erbium-Yttrium Aluminum Garnet (Er-YAG) laser therapy as a treatment for stress urinary incontinence
-
A new approach to predict cephalopelvic disproportion: three-dimension magnetic resonance imaging pelvic reconstruction. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-25 Neng Jin,Zhenyang Wang,Weizeng Zheng,Haoji Hu,Min Lv,Baihui Zhao,Qiong Luo
-
Clinical application of nanopore-based DNA sequencing for rapid, point-of-care, 24-chromosome aneuploidy testing of products of conception following a pregnancy loss. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-23 Shan Wei,Eric J Forman,Zev Williams
-
Cardiac structural, functional and energetic assessments during and after pregnancy in women with gestational diabetes mellitus, preeclampsia and healthy pregnancy. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-22 Sharmaine Thirunavukarasu,Faiza Ansari,Sindhoora Kotha,Marilena Giannoudi,Henry Procter,Lizette Cash,Amrit Chowdhary,Nicholas Jex,Hunain Shiwani,Karen Forbes,Ladislav Valkovič,Peter Kellman,Sven Plein,John P Greenwood,Thomas Everett,Eleanor M Scott,Eylem Levelt
BACKGROUND GDM and preeclampsia are common complications of pregnancy, for which overweight/obesity is a common risk factor. Both conditions are associated with a two-to-four-fold increase in future incident heart failure, which may be linked to early maladaptive myocardial changes. OBJECTIVES To determine maternal myocardial structural, functional, and energetic responses to pregnancies complicated
-
Assessing aspirin dosing for preeclampsia prevention: clarifying pharmacokinetics and pharmacodynamics Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-22 Renqi Luo PhD, Xue Ran MBBS, Ruihan Sun BEcon
-
Assisted reproductive technology and the risk of birth defects mediated by multifetal pregnancy: evidence from the China Birth Cohort Study. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-22 Ruohua Yan,Shen Gao,Xiaohang Liu,Ruixia Liu,Shaofei Su,Yaguang Peng,Xiaolu Nie,Enjie Zhang,Shuanghua Xie,Jianhui Liu,Yue Zhang,Wentao Yue,Xiaoxia Peng,Chenghong Yin
BACKGROUND Both assisted reproductive technology and multifetal pregnancy have been reported to be associated with an increased risk of birth defects. However, it is unclear whether multifetal pregnancy is a mediator that increases the risk of birth defects in assisted reproductive technology-conceived pregnancies. OBJECTIVE To investigate the risk of birth defects associated with assisted reproductive
-
DORA: Comparing 75 mg vs 150 mg aspirin in pregnant women at risk of pre-eclampsia. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-21 Raya Vinogradov,Oisín N Kavanagh,Farhad Kamali,Stephen Robson
-
Gestational age assessment by ultrasound cerebellar measurements in fetal and perinatal deaths. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-19 Núria Peñuelas,Adela Saco,Lorena Marimón,Laia Diez-Ahijado,Alfons Nadal,Lia Sisuashvili,Katarzyna Darecka,Eduard Gratacós,Fatima Crispi,Elena Monterde,Laura García-Otero,Gemma Arca,Quique Bassat,Raquel González,Clara Menéndez,Jaume Ordi,Natalia Rakislova
BACKGROUND Perinatal mortality remains high in low- and middle-income countries. Accurate assessment of fetal gestational age is crucial to distinguish between prematurity and intrauterine growth restriction, 2 conditions commonly associated with perinatal mortality that require different preventive strategies and management. Ultrasound measurements of the cerebellum have been shown to be accurate
-
Effect of fragmentation of surgery and adjuvant treatment in high-grade nonendometrioid endometrial cancer: a population-based cohort study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-15 Andra Nica MD MSc FRCSC, Rinku Sutradhar PhD, Rachel Kupets MD MSc FRCSC, Allan Covens MD FRCSC, Danielle Vicus MD MSc FRCSC, Qing Li MSc, Sarah E. Ferguson MD FRCSC, Lilian T. Gien MD MSc FRCSC
Fragmented care (FC) occurs when patients receive treatment across several different hospitals. Regionalization of surgery for patients with high-grade endometrial cancer means that patients must travel longer distances to receive care; these patients often require adjuvant treatment after surgery.
-
Fertility and age at childbirth in polycystic ovary syndrome: results from a longitudinal population-based cohort study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Maria Forslund MD PhD, Helena Teede MD PhD, Johanna Melin MD PhD, Chau Thien Tay MD PhD, Deborah Loxton MD PhD, Anju E. Joham MD PhD
There are few studies in unselected populations describing reproductive outcomes in women with polycystic ovary syndrome (PCOS) at the end of their reproductive years.
-
Improving care after stillbirth Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Lena C. Sweeney MD, Uma M. Reddy MD MPH, Xiao Xu PhD
-
Inclusion of pregnant or lactating individuals in industry-funded clinical trials Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Amanda Lalita Harrilal Khan PharmD MS ORISE Fellow, Abigail Melake BS, Leyla Sahin MD, Catherine Spong MD, Lynne Yao MD
-
Preventability of maternal deaths: the right measure is the one that can drive effective preventive responses Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Catherine Deneux-Tharaux MD PhD
-
Putting perinatal attention-deficit/hyperactivity disorder in context: intersecting across identities, diagnoses, and generations Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Olivia Scoten BSc, Katarina Tabi PhD, Catriona Hippman PhD
-
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Hiba J. Mustafa MD, Enaja V. Sambatur MD, Alireza A. Shamshirsaz MD, Sonia Johnson MD, Kenneth J. Moise Jr. MD, Ahmet A. Baschat MD, E.J.T. (Joanne) Verweij MD, Ali Javinani MD, Mark D. Kilby MD DSc, Enrico Lopriore MD, Rebecca Rose MD, Roland Devlieger MD, Saul Snowise MD, Ulrich J. Sachs MD, Asma Khalil MD MSc, HDFN Delphi Working Group, Ahmed A. Nassr, Ahmet Baschat, Alexander Hohnecker, Alireza
The study aimed to develop structured, expert-based clinical guidance on the prenatal and postnatal management of hemolytic disease of the fetus and newborn. A Delphi procedure was conducted among an international panel of experts in fetal medicine, neonatology, and hematology. Experts were selected based on their expertise, relevant publications, and affiliations. The domains were (i) prenatal workup
-
Racism as a modifiable risk factor Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Elliot M. Levine MD
-
National standards needed for maternal death preventability assessments in the United States Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Andreea A. Creanga MD, Jiage Qian MSPH, Carrie Wolfson PhD
-
Not just a simple diagnosis of attention-deficit/hyperactivity disorder Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Meenal M. Joshi B.S. Biology, Keisha R. Callins MD MPH
-
Effect of aspirin on biomarker profile in women at high risk for preeclampsia. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-14 Long Nguyen-Hoang,Daljit S Sahota,Angela S T Tai,Yunyu Chen,Qiaoli Feng,Xueqin Wang,Sakita Moungmaithong,Maran B W Leung,Ada W Tse,Natalie K L Wong,Angel H Kwan,So Ling Lau,Nikki M W Lee,Marc K C Chong,Liona C Poon
BACKGROUND There is limited evidence in the literature regarding the temporal changes of preeclampsia-related biomarkers during pregnancy in high-risk women who develop preeclampsia despite the administration of aspirin prophylaxis. OBJECTIVE This study aimed to compare the temporal changes in mean arterial pressure, uterine artery pulsatility index, placental growth factor, and soluble fms-like tyrosine
-
The role of social work in reducing the risk of postpartum readmission. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-13 Zeqing Du,Shizhao Wang,Luyang Su
-
Homozygous missense variations of APC12 cause meiotic metaphase I arrest in oocytes and female infertility. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-12 Yunying Lin,Zhe Wei,Ling Zhang,Yejie Yao,Yi Huang,Guangxin Yao,Wangsheng Wang,Shuanggang Hu,Ying Ding,Yao Lu,Xuejiao Bian,Xinyi Dong,Hengyu Guan,Yunfei Huang,Yun Sun
BACKGROUND Oocyte maturation arrest is a leading cause of female infertility. However, the genetic variables remain largely unknown. In oocytes, the activation of anaphase-promoting complex/cyclosome (APC/C) is a critical step in the transition from meiosis I to meiosis II. However, the causal relationship between variants in APC/C components and female infertility hasn't been completely investigated
-
Maternal body mass index, maneuvers, and neonatal morbidity associated with shoulder dystocia Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Aneesha Cheedalla MD, Alyssa Thompson MD, Emily Fortman BA, Jennifer L. Grasch MD, Kartik K. Venkatesh MD PhD, Mark B. Landon MD, Heather A. Frey MD MCSI
Shoulder dystocia is associated with neonatal morbidity. Higher maternal prepregnancy body mass index is an established risk factor for shoulder dystocia, yet the relationship between maternal prepregnancy body mass index and resulting neonatal morbidity after shoulder dystocia is not well-studied.
-
Maternal positioning during cesarean delivery complicated by impacted fetal head Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Katie R. Cornthwaite PhD, Rachna Bahl MD, Katherine Lattey MRCOG MRes, Tim Draycott MRCOG MD
-
Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Mary E. Beste MD, Andrew M. Kaunitz MD, Jordan A. McKinney MD MBA, Luis Sanchez-Ramos MD
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of menopause.
-
A multidisciplinary approach to addressing the impact of maternal depression on child development: urgent need for early intervention and comprehensive care Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Ren Xu MD, Yanan Ren MD, Jianzhi Su MD
-
Addressing limitations and expanding perspectives of blood pressure control in pregnancies complicated by diabetes Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Lorie M. Harper MD MSCI, Jeff M. Szychowski PhD, Alan T.N. Tita MD
-
Bladder health in US women: population-based estimates from the RISE FOR HEALTH study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Ariana L. Smith MD, Chloe Falke BS, Kyle D. Rudser PhD, Gerald McGwin PhD, Sonya S. Brady PhD, Linda Brubaker MD, Kimberly Kenton MD, D. Yvette LaCoursiere MD MPH, Cora E. Lewis MD, Lisa K. Low PhD, Jerry L. Lowder MD, Emily S. Lukacz MD, Elizabeth R. Mueller MD, Diane K. Newman DNP, Jesse Nodora DrPH, Alayne Markland MD, Sara Putnam MS, Leslie M. Rickey MD MPH, Todd Rockwood PhD, Melissa A. Simon
Bladder health encompasses total bladder well-being and not merely the absence of urinary symptoms. While much is known about the prevalence of urinary symptoms in women, little is known about the distribution of bladder health (eg, optimal to poor).
-
The impact of body mass index on the risk of postoperative complications following myomectomy Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Michal Axelrod MD MPH, Kacey M. Hamilton MD, Rebecca J. Schneyer MD, Gabriel Levin MD, Yotam Weiss MD, Mireille D. Truong MD, Kelly N. Wright MD, Matthew T. Siedhoff MD MSCR, Raanan Meyer MD
Uterine leiomyomas are common benign neoplasms, often causing symptoms like abnormal uterine bleeding, pelvic pain, and subfertility, with treatment options ranging from medical management to surgical interventions such as myomectomy. While myomectomy is effective in symptom relief, the impact of body mass index (BMI) on postoperative complications remains underexplored, warranting further investigation
-
TREATMENT OF EARLY-ONSET FETAL GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN DOES NOT PROLONG GESTATION: A RANDOMIZED CLINICAL TRIAL. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Alba González,Anna Peguero,Eva Meler,Marta Camprubí-Camprubí,Carlota Rovira,Maria Dolores Gomez-Roig,Daniel Oros,Patricia Ibáñez-Burillo,Jon Schoorlemmer,Narcís Masoller,Maria Dolors Tàssies,Francesc Figueras,Edurne Mazarico
BACKGROUND Although there is a biological basis for it, there is scarce evidence on the effect of heparin in ameliorating placental insufficiency and maximizing gestational age at delivery among fetal growth restriction (FGR) pregnancies. OBJECTIVE To explore the effectiveness of treatment using low molecular weight heparin (LMWH) at a prophylactic dose started at the time of diagnosis in prolonging
-
First-trimester maternal ophthalmic artery Doppler is associated with insulin-treated gestational diabetes mellitus Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Christos Chatzakis PhD, Marietta Charakida PhD, Kypros H. Nicolaides PhD
-
Clarifying methodologic choices and future directions in hypertension research Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Lorie M. Harper MD MSCI, Jeff M. Szychowski PhD, Alan T.N. Tita MD
-
Association of premature natural and surgical menopause with incidence of depression requiring hospitalization: a prospective cohort study Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Minzhi Xu PhD, Xiaoxv Yin PhD, Yanhong Gong PhD
Premature menopause is associated with depression in postmenopausal women. However, current evidence ignores the differences between premature natural and surgical menopause, and there is a lack of exploration of the mechanisms underlying the association between premature menopause and depression.
-
Aspirin discontinuation in high-risk preeclampsia: the role of vascular vs placental factors–authors’ reply Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Daniel L. Rolnik MD PhD MPH, David Wright PhD, Kypros H. Nicolaides MD
-
Understanding the performance of 2 large language models in Obstetrics and Gynecology Maintenance of Certification Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Anthony Sparks PhD, Heath Kincaid BS, Pooja Shivraj MS PhD, Amy Young MD
-
Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Olyvia J. Jasset BA, Paola Andrea Lopez Zapana PhD, Zeynep Bahadir MD, Lydia Shook MD, Maria Dennis BS, Emily Gilbert BA, Zhaojing Ariel Liu BA, Rachel V. Yinger BS, Caroline Bald BS, Caroline G. Bradford BS, Alexa H. Silfen BA, Sabra L. Klein PhD, Andrew Pekosz PhD, Sallie Permar MD PhD, Liza Konnikova MD PhD, Lael M. Yonker MD, Douglas Lauffenburger PhD, Ashley Nelson PhD, Michal A. Elovitz MD, Andrea
Respiratory syncytial virus is associated with significant neonatal and infant morbidity and mortality. Maternal bivalent respiratory syncytial virus prefusion F respiratory syncytial virus vaccination to protect neonates and infants was approved in September 2023 for administration between 32+0 and 36+6 weeks to protect neonates and infants. This approved timeframe is narrower than the 24 to 36 week
-
Aspirin discontinuation in high-risk preeclampsia: the role of vascular vs placental factors Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Mohammadamin Noorafrooz MD, Mohadese Dashtkoohi MD, Sedigheh Hantoushzadeh MD
-
Vascular resistance and gestational diabetes mellitus: correlation or coincidence? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2024-11-07 Lily Robistow BS, Hannah Smith BSc, Christine Vo MD FASA